NYSE:USNA USANA Health Sciences (USNA) Stock Price, News & Analysis $13.26 +0.53 (+4.12%) Closing price 11/13/2026 03:59 PM EasternExtended Trading$13.18 -0.07 (-0.53%) As of 11/13/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About USANA Health Sciences Stock (NYSE:USNA) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get USANA Health Sciences alerts:Sign Up Key Stats Today's Range$12.89▼$13.4850-Day Range$12.70▼$15.4852-Week Range$12.52▼$23.59Volume167,450 shsAverage Volume203,581 shsMarket Capitalization$244.95 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview USANA Health Sciences, Inc. develops and sells nutritional supplements, personal care products and foods. Its offerings include vitamins and other nutrition products, skincare products under the Celavive brand, and nutrition bars. Founded in 1992 by Myron Wentz, the company uses a direct-selling model, with independent Associates and other sales channels connecting its products with customers. USANA serves markets across North America, Asia-Pacific and other international regions.AI Generated. May Contain Errors. Read More USANA Health Sciences Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks27th Percentile Overall ScoreUSNA MarketRank™: 1.35115606936 of 5 starsUSANA Health Sciences scored higher than 27% of companies evaluated by MarketBeat, and ranked 142nd out of 168 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.9 / 5Analyst RatingSell Consensus RatingUSANA Health Sciences has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 2 sell ratings.Amount of Analyst CoverageUSANA Health Sciences has only been the subject of 2 research reports in the past 90 days.Read more about USANA Health Sciences' stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth127.27% Earnings GrowthEarnings for USANA Health Sciences are expected to grow by 127.27% in the coming year, from $0.55 to $1.25 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of USANA Health Sciences is -11.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of USANA Health Sciences is -11.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioUSANA Health Sciences has a PEG Ratio of 1.93. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioUSANA Health Sciences has a P/B Ratio of 0.46. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted4.80% of the float of USANA Health Sciences has been sold short.Short Interest Ratio / Days to CoverUSANA Health Sciences has a short interest ratio ("days to cover") of 5.15.Change versus previous monthShort interest in USANA Health Sciences has recently increased by 12.86%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldUSANA Health Sciences does not currently pay a dividend.Dividend GrowthUSANA Health Sciences does not have a long track record of dividend growth. News and Social Media2.6 / 5News Sentiment0.17 News SentimentUSANA Health Sciences has a news sentiment score of 0.17. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Consumer Staples companies.News Coverage This WeekMarketBeat has tracked 7 news articles for USANA Health Sciences this week, compared to 3 articles on an average week.MarketBeat Follows1 people have added USANA Health Sciences to their MarketBeat watchlist in the last 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, USANA Health Sciences insiders have not sold or bought any company stock.Percentage Held by Insiders0.82% of the stock of USANA Health Sciences is held by insiders.Percentage Held by Institutions54.25% of the stock of USANA Health Sciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about USANA Health Sciences' insider trading history. Receive USNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for USANA Health Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. USNA Stock News HeadlinesUSANA Health Sciences (USNA) Stock Falls on Q3 2026 EarningsNovember 12 at 2:51 PM | quiverquant.comQUSANA Health Sciences FY2027 Earnings Forecast Cut by SidotiNovember 12 at 2:13 AM | americanbankingnews.comI'm handing you this one freeElon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds. He licenses it from one overlooked company. That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th.November 15 at 1:00 AM | Behind the Markets (Ad)USANA Health Sciences Earnings Call Signals Mixed ProgressNovember 9, 2026 | tipranks.comQ1 EPS Forecast for USANA Health Sciences Reduced by AnalystNovember 9, 2026 | americanbankingnews.comSidoti Analysts Decrease Earnings Estimates for USNANovember 8, 2026 | americanbankingnews.comQ4 EPS Estimate for USANA Health Sciences Raised by AnalystNovember 7, 2026 | americanbankingnews.comUSANA Health Sciences, Inc. Updates Earnings Guidance for Fiscal Year 2026November 5, 2026 | marketscreener.comMSee More Headlines USNA Stock Analysis - Frequently Asked Questions How have USNA shares performed this year? USANA Health Sciences' stock was trading at $19.61 at the beginning of the year. Since then, USNA stock has decreased by 32.4% and is now trading at $13.2550. How were USANA Health Sciences' earnings last quarter? USANA Health Sciences, Inc. (NYSE:USNA) posted its earnings results on Tuesday, November, 3rd. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.11 by $0.22. The business earned $205.89 million during the quarter, compared to analysts' expectations of $217.42 million. USANA Health Sciences had a negative net margin of 2.34% and a positive trailing twelve-month return on equity of 3.56%. Read the conference call transcript. Who are USANA Health Sciences' major shareholders? USANA Health Sciences' top institutional investors include Pzena Investment Management LLC (6.03%), Nantahala Capital Management LLC (5.35%), State Street Corp (1.32%) and Marshall Wace LLP (0.55%). Insiders that own company stock include Myron W Wentz, Jim Brown, Kevin Guest, David Mulham Mulham, Frederic J Winssinger, John Turman Fleming, Peggie Pelosi, Walter Noot, Robert A Sinnott, Paul A Jones, Joshua Foukas, Gilbert A Fuller, G Doug Iiekking, Daniel A Macuga and Brent Neidig. View institutional ownership trends. How do I buy shares of USANA Health Sciences? Shares of USNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of USANA Health Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that USANA Health Sciences investors own include NVIDIA (NVDA), Nu Skin Enterprises (NUS), Procter & Gamble (PG), Herbalife (HLF), International Business Machines (IBM), Tesla (TSLA) and Best Buy (BBY). Company Calendar Last Earnings11/03/2026Today11/15/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (3m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 USNA's financial health is in the Red zone, according to TradeSmith. USNA has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorConsumer Staples Industry Personal Care Products Sub-IndustryPersonal Care Products Current SymbolNYSE:USNA CIK896264 Webwww.usana.com Phone(801) 954-7100Fax801-954-7300Employees1,570Year Founded1992Profitability EPS (Trailing Twelve Months)($1.15) Trailing P/E RatioN/A Forward P/E Ratio10.60 P/E Growth1.93Net Income$10.76 million Net Margins-2.34% Pretax Margin-0.01% Return on Equity3.56% Return on Assets2.62% Debt Debt-to-Equity RatioN/A Current Ratio2.59 Quick Ratio1.84 Sales & Book Value Annual Sales$925.26 million Price / Sales0.26 Cash Flow$4.30 per share Price / Cash Flow3.08 Book Value$28.51 per share Price / Book0.46Miscellaneous Outstanding Shares18,480,000Free Float18,325,000Market Cap$244.95 million OptionableOptionable Beta0.66 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NYSE:USNA) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredUnbelievable…Congress is About to Do What?Jim Rickards, former advisor to the CIA, the Pentagon and the White House, says a key turning point in Washing...Paradigm Press | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding USANA Health Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share USANA Health Sciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.